An Open Label, Multicenter, Non Randomized Phase II Study to Evaluate Antitumor Efficacy and Safety of GM-CSF (Sargramostim, Leukine) Associated With RCHOP Chemotherapy and Rituximab (MabThera) Maintenance in Patients With First-line Advanced Follicular Non Hodgkin's Lymphoma
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2016
At a glance
- Drugs Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Sargramostim; Vincristine
- Indications Non-Hodgkin's lymphoma
- Focus Biomarker; Therapeutic Use
- 24 Mar 2012 Actual initiation date (19 Sep 2008) added as reported by European Clinical Trials Database.
- 24 Mar 2012 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.
- 13 May 2009 New trial record